Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Martin

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
BJGP Open|December 9, 2020
Evaluating the delay prior to primary care presentation in patients with lung cancer: a cohort studyJalpa Kotecha, Allan Clark, Matthew Burton, et al.
Medical Physics|July 21, 2009
An overview of the comprehensive proton therapy machine quality assurance procedures implemented at The University of Texas M. D. Anderson Cancer Center Proton Therapy Center-HoustonBijan Arjomandy, Narayan Sahoo, X Ronald Zhu, et al.
Medical Physics|February 24, 2010
Commissioning of the discrete spot scanning proton beam delivery system at the University of Texas M.D. Anderson Cancer Center, Proton Therapy Center, HoustonMichael T Gillin, Narayan Sahoo, Martin Bues, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 1, 2026
Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early Preterm Birth in Australia Compared with Current PracticeHossein Haji Ali Afzali, Ecushla Linedale, Craig Martin, et al.
The Cochrane Database of Systematic Reviews|April 10, 2024
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settingsAlexandru Marian Constantin, Kukuh Noertjojo, Isolde Sommer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2010
Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinomaAngela Stokes, Juho Joutsa, Risto Ala-Aho, et al.
Harm Reduction Journal|September 19, 2024
Key stakeholders' perspectives of illicit drug use and associated harms in the Northern Territory of AustraliaBryce Brickley, Samuel Moore, Noemi Tari-Keresztes, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2011
Patient-specific quality assurance for prostate cancer patients receiving spot scanning proton therapy using single-field uniform doseX Ronald Zhu, Falk Poenisch, Xiaofei Song, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitorsAndrew Baxter, Steve Brough, Anne Cooper, et al.
The Cochrane Database of Systematic Reviews|May 6, 2022
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settingsAna Beatriz Pizarro, Emma Persad, Solange Durao, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
BJGP Open|December 9, 2020
Evaluating the delay prior to primary care presentation in patients with lung cancer: a cohort studyJalpa Kotecha, Allan Clark, Matthew Burton, et al.
Medical Physics|July 21, 2009
An overview of the comprehensive proton therapy machine quality assurance procedures implemented at The University of Texas M. D. Anderson Cancer Center Proton Therapy Center-HoustonBijan Arjomandy, Narayan Sahoo, X Ronald Zhu, et al.
Medical Physics|February 24, 2010
Commissioning of the discrete spot scanning proton beam delivery system at the University of Texas M.D. Anderson Cancer Center, Proton Therapy Center, HoustonMichael T Gillin, Narayan Sahoo, Martin Bues, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 1, 2026
Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early Preterm Birth in Australia Compared with Current PracticeHossein Haji Ali Afzali, Ecushla Linedale, Craig Martin, et al.
The Cochrane Database of Systematic Reviews|April 10, 2024
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settingsAlexandru Marian Constantin, Kukuh Noertjojo, Isolde Sommer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2010
Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinomaAngela Stokes, Juho Joutsa, Risto Ala-Aho, et al.
Harm Reduction Journal|September 19, 2024
Key stakeholders' perspectives of illicit drug use and associated harms in the Northern Territory of AustraliaBryce Brickley, Samuel Moore, Noemi Tari-Keresztes, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2011
Patient-specific quality assurance for prostate cancer patients receiving spot scanning proton therapy using single-field uniform doseX Ronald Zhu, Falk Poenisch, Xiaofei Song, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitorsAndrew Baxter, Steve Brough, Anne Cooper, et al.
The Cochrane Database of Systematic Reviews|May 6, 2022
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settingsAna Beatriz Pizarro, Emma Persad, Solange Durao, et al.
Pageof 5